Outset Medical is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System is an enterprise solution approved for use across the entire continuum of care — from hospital to home, allowing dialysis to be delivered anytime, anywhere, by anyone.
website: outsetmedical.com
NephU – Through increased awareness, collaboration, and information-sharing, our mission is to improve the future outcomes for individuals with kidney disease and other related conditions. NephU offers your organization private, in-person and virtual educational programs on a range of kidney health topics. future outcomes for individuals with kidney disease and other related conditions.
website: https://nephu.org/
This activity will be jointly provided by Medical Education Resources (MER) and the University of Missouri.
MER is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MER is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and Missouri Institute of Mental Health. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Credit
Medical Education Resources designates this live activity for a maximum of 21.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit
Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This CE activity provides 21.75 contact hours of continuing nursing education.
Provider approved by the California Board of Registered Nursing, Provider Number 12299, for 21.75 contact hours.
Missouri Institute of Mental Health (MIMH) Accreditation (behavioral health professionals):
The University of Missouri-St. Louis, Missouri Institute of Mental Health will be responsible for this program and maintain a record of your continuing education credits earned.
Missouri Institute of Mental Health will award up to 21.75 clock hours
National Board for Certified Counselors (NBCC) Accreditation:
MIMH has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 6339. Programs that do not qualify for NBCC credit are clearly identified. MIMH is solely responsible for all aspects of the programs.
Up to 21.75 clock hours are offered for this program.
Commission on Dietetic Registration (CDR) Accreditation:
The University of Missouri has submitted the Annual Dialysis Conference to the Commission on Dietetic Registration for up to 21.75 clock hours of accreditation for dietitians.
A leader in dialysis access and renal care solutions. Explore our educational resources and training videos on acute/chronic hemodialysis, including a 1-Credit CE course on Maximizing the Success of Catheter-Based Hemodialysis.
website: Medtronic.com
Sanofi Genzyme, the specialty care global business unit of Sanofi, focuses on rare diseases, rare blood disorders, neurology & immunology, oncology, and type 2 inflammation. We help people with debilitating and complex conditions that are often difficult to diagnose and treat. Our approach is shaped by our experience developing highly specialized treatments and forging close relationships with physician and patient communities. We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world.
Learn more at www.sanofigenzyme.com
website: https://www.sanofigenzyme.com
Founded in Lawrence, MA in 1998, NxStage, from Fresenius Medical Care, is transforming dialysis therapy technology every day through manufacturing innovative products for the treatment of end-stage renal disease (ESRD) and acute kidney failure. NxStage champions research, education and patient-advocacy above all else and is pioneering better care for people with end-stage renal disease (ESRD).
Fresenius Renal Pharmaceuticals specializes in the prescription needs of the ESRD patient and is dedicated to providing pharmaceuticals to the more than 400,000 individuals undergoing dialysis throughout the United States.
Our renal pharmaceutical products include Velphoro® (sucroferric oxyhydroxide) chewable tablets, Venofer® (iron sucrose injection USP) and PhosLyra® (calcium acetate oral solution).
website: https://www.velphorohcp.com/
Headquartered in Waltham, MA, Fresenius Medical Care North America (FMCNA) is revolutionizing clinical and home hemodialysis environments with the most advanced equipment, pharmaceuticals, research and advocacy in the industry. With 35+ years of experience, FMCNA is dedicated to transforming healthcare and improving the quality of life for people living with kidney disease.
website: https://fmcna.com/products/